Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Harmony Biosciences revenue
Harmony Biosciences's revenue is $714.7 million.
What is Harmony Biosciences's revenue?
- Harmony Biosciences's revenue growth from 2019 to 2024 is 11,822.17%.
- Harmony Biosciences has 214 employees, and the revenue per employee ratio is $3,339,878.
- Harmony Biosciences's peak quarterly revenue was $201.3M in 2024(q4).
- Harmony Biosciences peak revenue was $714.7M in 2024.
- Harmony Biosciences annual revenue for 2023 was 582.0M, 32.93% growth from 2022.
- Harmony Biosciences annual revenue for 2024 was 714.7M, 22.8% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Harmony Biosciences historical revenue
Harmony Biosciences's peak revenue was $714.7M in 2024. The peak quarterly revenue was $201.3M in 2024(q4).
Harmony Biosciences's revenue increased from $6.0m in 2019 to $714.7M currently. That's a 11,822.17% change in annual revenue.
Harmony Biosciences annual revenue
Harmony Biosciences annual revenue over time
| Fiscal year / year | Harmony Biosciences revenue |
|---|---|
| 2019 | $6.0M |
| 2020 | $159.7M |
| 2021 | $305.4M |
| 2022 | $437.9M |
| 2023 | $582.0M |
| 2024 | $714.7M |
Rate Harmony Biosciences' financial transparency
Harmony Biosciences annual growth
Harmony Biosciences saw the greatest revenue growth in 2020, when revenue increased by 2,564.59%.
Harmony Biosciences had the lowest revenue growth in 2022, when revenue changed by 43.35%.
Harmony Biosciences annual growth rate over time
| Year | Harmony Biosciences growth |
|---|---|
| 2020 | 2565%↑ |
| 2021 | 91%↑ |
| 2022 | 43%↑ |
| 2023 | 33%↑ |
| 2024 | 23%↑ |
Harmony Biosciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Harmony Biosciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $45.6M | $56.3M |
| 2021 | $59.7M | $73.8M | $80.7M | $91.2M |
| 2022 | $85.3M | $107.0M | $117.2M | $128.3M |
| 2023 | $119.1M | $134.2M | $160.3M | $168.4M |
| 2024 | $154.6M | $172.8M | $186.0M | $201.3M |
Harmony Biosciences jobs nearby
Do you work at Harmony Biosciences?
Is Harmony Biosciences transparent about its revenue structure?
Harmony Biosciences financial information
| CEO | John C.s Jacobs |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 214 |
| Date Founded | 2017 |
| Headquarters | Plymouth Meeting, Pennsylvania |
| Number of Locations | 1 |
| Revenue | $714.7M |
| Net Income | $181,468,000 |
| Gross Proft | $557.9M (2024) |
| Tax Rate | 0.2% |
| Total Assets | $673,870,000 |
| Ticker | HRMY |
Harmony Biosciences jobs you might like
Harmony Biosciences financing
Harmony Biosciences received early financing of $270.0M on 2017-10-06.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $270M | 10/2017 |
| Debt Financing | $200M | 03/2019 |
| Series C | $50M | 08/2019 |
| Debt Financing | $200M | 01/2020 |
| Post Ipo Debt | $300M | 08/2021 |
| Post Ipo Equity | $30M | 08/2021 |
Harmony Biosciences investors
| Investors | Security type |
|---|---|
| HBM Healthcare Investments AG | Series Unknown |
| Nan Fung Life Sciences | Series Unknown |
| Valor Equity Partners | Series Unknown |
| Vivo Capital | Series Unknown |
| venBio Partners | Series Unknown |
| Fmr | Series Unknown |
| Novo Holding | Series Unknown |
| CRG LP | Debt Financing |
| HBM Healthcare Investments AG | Series C |
| OrbiMed Advisors | Debt Financing |
| The Blackstone Group Inc. | Post Ipo Debt |
| Blackstone Life Sciences | Post Ipo Equity |
Harmony Biosciences competitors
Harmony Biosciences's top competitor, Axsome Therapeutics, earned an annual revenue of $385.7M.
Harmony Biosciences's smallest competitor is Edgewise Therapeutics with revenue of $30.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cerecor | - | $6.7M | 32 | - |
| Seelos Therapeutics | - | $375,000 | 10 | - |
| Lumos Pharma | - | $2.1M | 20 | - |
| Accera | - | $5.5M | 75 | - |
| BridgeBio | - | $221.9M | 396 | - |
| Axsome Therapeutics | - | $385.7M | 29 | - |
| Hemostemix | - | $284.9K | 8 | - |
| Edgewise Therapeutics | - | $30,000 | 45 | - |
| Nabriva Therapeutics | - | $12.0M | 175 | - |
| Stealth BioTherapeutics | - | $21.1M | 52 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Harmony Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Harmony Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Harmony Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Harmony Biosciences. The data presented on this page does not represent the view of Harmony Biosciences and its employees or that of Zippia.
Harmony Biosciences may also be known as or be related to Harmony Biosciences and Harmony Biosciences, LLC.